The Pharmacology Center

Filter Your Results

 

News

 

Expert Consensus Statement Addresses Anesthesia Practices in Pediatric Congenital Cath Labs

November 11, 2016 -- The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA), and the Congenital Cardiac Anesthesia Soc…

Two-Year LEADERS FREE Data Presented for BioSensors’ BioFreedom Drug-Coated Stent

October 30, 2016 -- The 2-year results from LEADERS FREE were reported at TCT 2016, the 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Was…

Two Real-World Studies Evaluate Xarelto in Treating VTE

October 23, 2016 -- Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, announced results of two real-world studies confirming the benefit-risk profil…

Study Shows Importance of Adherence to Medical Therapy on Long-Term Outcomes Regardless of Revascularization Strategy

October 24, 2016 -- An evaluation of the impact of adherence to medical therapy on comparative outcomes of coronary artery bypass graft (CABG) versus percutaneous coronary int…

Do the New DAPT Guidelines Result in Any Real Changes in Practice?

With John A. Bittl, MD; Robert Yeh, MD, MSc, MBA; Eric A. Secemsky, MD, MSc; Eric R. Bates, MD; and Issam D. Moussa, MD, FACC, FAHA, FSCAI

September/October 2016— John A. Bittl, MD Interventional Cardiologist Munroe Regional Medical Center Ocala, Florida johnbittl7@gmail.com Disclosures: None./em

Study Evaluates Safety and Efficacy of DAPT After Complex PCI

October 17, 2016 -- An investigation of the safety and efficacy of long-term (≥ 12 months) versus short-term (3 or 6 months) dual-antiplatelet therapy (DAPT) with aspi…

Amgen’s Cholesterol-Lowering Repatha Meets Endpoints in GLAGOV IVUS Imaging Study

September 27, 2016 -- Amgen announced last week that the phase 3 GLAGOV trial evaluating the effect of the company’s Repatha (evolocumab) medication on coronary artery d…

FDA Approves Bolus Vial Format for Medicure’s Aggrastat

September 1, 2016 -- Medicure Inc. announced that it has received approval from the US Food and Drug Administration (FDA) for its new "bolus vial" product format for…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.